EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Unraveling pH Regulation of TMEM175, an Endolysosomal Cation Channel With a Role in Parkinson's Disease

Tobias Schulze, Oliver Rauh, Gerhard Thiel, Niels Fertig, Andre Bazzone, Christian Grimm iD

Journal of Cellular Physiology · 2025

DOI: 10.1002/jcp.70008 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cellular Physiology, 2025. Verfasst von Tobias Schulze und 5 weiteren Autor:innen. Beteiligte Einrichtung: Walther Straub Institute of Pharmacology and Toxicology, Faculty of Medicine, Ludwig-Maximilians-University, Munich, Germany. Hauptthemen laut MEDLINE: Parkinson Disease, Lysosomes, Endosomes, Ion Channels. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transmembrane protein 175 (TMEM175) is an endolysosomal cation channel, which has attracted much attention recently from academics and the pharmaceutical industry alike since human mutations in TMEM175 were found to be associated with the development of Parkinson's disease (PD). Thus, gain‐of‐function mutations were identified, which reduce and loss‐of‐function mutations, which increase the risk of developing PD. After having been characterized as an endolysosomal potassium channel initially, soon after TMEM175 was claimed to act as a proton channel. In fact, recent evidence suggests that depending on the conditions, TMEM175 can act as either a potassium or proton channel, without acting as an antiporter or exchanger. A recent work has now identified amino acid H57 to be directly involved in gating, increasing proton conductance of the channel while leaving the potassium conductance unaffected. We review here the current knowledge of TMEM175 function, pharmacology, physiology, and pathophysiology. We discuss the potential of this ion channel as a novel drug target for the treatment of neurodegenerative diseases such as PD, and we discuss the discovery of H57 as proton sensor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseLysosomesEndosomesIon ChannelsPotassium ChannelsHumansHydrogen-Ion ConcentrationAnimalsMutation

Stichwörter der Autor:innen

PDTMEM175endosomelysosomeneurodegenerative disease

Substanzen

TMEM175 protein, humanIon ChannelsPotassium Channels

Autor:innen und Institutionen

  • Walther Straub Institute of Pharmacology and Toxicology, Faculty of Medicine, Ludwig-Maximilians-University, Munich, Germany.
  • Department of Natural Sciences, Institute for Functional Gene Analytics, Bonn-Rhein-Sieg University of Applied Sciences, Rheinbach, Germany.
  • Department of Biology, Membrane Biophysics, Darmstadt, Germany.
  • Nanion Technologies, Munich, Germany.
  • Immunology, Infection and Pandemic Research IIP, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Munich/Frankfurt, Germany.

ORCID-Profile: Christian Grimm

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Schulze, T., Rauh, O., Thiel, G., Fertig, N., Bazzone, A., & Grimm, C. (2025). Unraveling pH Regulation of TMEM175, an Endolysosomal Cation Channel With a Role in Parkinson's Disease. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.70008

Vancouver

Schulze T, Rauh O, Thiel G, Fertig N, Bazzone A, Grimm C. Unraveling pH Regulation of TMEM175, an Endolysosomal Cation Channel With a Role in Parkinson's Disease. Journal of Cellular Physiology. 2025. doi:10.1002/jcp.70008

BibTeX
@article{Schulze2025,
  author = {Schulze, Tobias and Rauh, Oliver and Thiel, Gerhard and Fertig, Niels and Bazzone, Andre and Grimm, Christian},
  title = {Unraveling pH Regulation of TMEM175, an Endolysosomal Cation Channel With a Role in Parkinson's Disease},
  journal = {Journal of Cellular Physiology},
  year = {2025},
  doi = {10.1002/jcp.70008}
}
Kostenlos starten →